Grantham, Mayo, Van Otterloo & Co (GMO)’s Plexus PLXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-22,548
Closed -$2.16M 752
2021
Q4
$2.16M Sell
22,548
-3,346
-13% -$309K 0.01% 452
2021
Q3
$2.31M Buy
+25,894
New +$2.3M 0.01% 438
2020
Q3
Sell
-4,682
Closed -$330K 814
2020
Q2
$330K Sell
4,682
-60,618
-93% -$3.76M ﹤0.01% 666
2020
Q1
$3.56M Buy
65,300
+55,600
+573% +$3.75M 0.03% 291
2019
Q4
$746K Sell
9,700
-9,700
-50% -$704K 0.01% 550
2019
Q3
$1.21M Buy
+19,400
New +$1.15M 0.01% 514

Other funds holding PLXS

Grantham, Mayo, Van Otterloo & Co (GMO)'s PLXS Position: Q1 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Plexus (PLXS) in Q1 2022, closing a stake of 22,548 shares — an estimated $2.16M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PLXS in Q3 2019 and held it in 6 quarters. The position peaked at $3.56M in Q1 2020. 216 funds tracked by Wall St. Rank hold PLXS as of Q1 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Plexus position as of Q1 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 22,548 Plexus shares in Q1 2022, an estimated $2.16M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Plexus in Q3 2019 and held it in 6 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Plexus position peaked at $3.56M in Q1 2020.
  • 216 funds tracked by Wall St. Rank held Plexus as of Q1 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2022, filed 13 May 2022.